Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The JointJYNT -0.35%64 FCF Margin % is 12.75% as of Jun. 2026, which is 65% above its 10-year median of 7.75. GuruFocus rates JYNT with a GF Score™ of 64/100 and a GF Value™ of $11.45 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 666 Healthcare Providers & Services companies, The Joint ranks better than 63.81% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. The Joint's Free Cash Flow for the
three
months ended in Jun. 2026 was $1.94 Mil. The Joint's Revenue for the
three
months ended in Jun. 2026 was $15.18 Mil. Therefore, The Joint's FCF Margin % for the quarter that ended in Jun. 2026 was 12.75%.
The historical data trend for The Joint's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, The Joint's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Joint FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Joint's FCF Margin % distribution charts can be found below:
* The bar in red indicates where The Joint's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Joint (JYNT) has a FCF Margin % of 12.75% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on The Joint and its competitors. This is 65% above median its historical median of 7.75. According to the industry distribution chart, The Joint ranks #241 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 36.2%.
Is The Joint's FCF Margin % too high?
The Joint's current FCF Margin % of 12.75% is 65% above median its 10-year median of 7.75. The Healthcare Providers & Services industry median FCF Margin % is 3.07. The Joint's value of 12.75% is 315.3% above this industry median. Based on the distribution chart, The Joint ranks #241 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, The Joint has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Joint's FCF Margin % compare to WW and PARK?
According to the Healthcare Providers & Services industry distribution chart, The Joint ranks #241 out of 666 companies for FCF Margin %. This puts The Joint in the upper half of its industry. The industry median FCF Margin % is 3.07. The Joint's value of 12.75% is 315.3% above this benchmark. While the company's 10-year median is 7.75 vs. the industry median of 3.07, The Joint has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.07, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Joint's current FCF Margin % of 12.75% is 315.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on The Joint and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Joint's current FCF Margin % is 12.75%, which is 65% above median its own 10-year median of 7.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Joint stock overvalued right now?
Based on GuruFocus' analysis, The Joint (JYNT) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.45, compared to a current price of $8.58 — trading 25.1% below its estimated fair value. The current FCF Margin % is 12.75%, which is 65% above median its 10-year median of 7.75 and 315.3% above the Healthcare Providers & Services industry median of 3.07. The Joint's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For The Joint (JYNT), the current FCF Margin % is 12.75% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Joint (JYNT) Overvalued in 2026?
Based on GuruFocus' analysis, The Joint stock appears to be undervalued.
The current stock price of $8.58 is trading 25.1% below its estimated GF Value™ of $11.45.
GuruFocus considers The Joint to be Modestly Undervalued.
Key valuation signals for JYNT:
FCF Margin %: 12.75% (65% above median its 10-year median of 7.75)
GF Value™: $11.45 vs. price of $8.58 (25.1% below fair value)
Industry Position: 315.3% above the Healthcare Providers & Services median (#241 of 666)
No single metric tells the full story. See the JYNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.
64GF Score
Get the complete analysis for JYNT
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JYNT has been successfully added to your 
